NMDA and opioid receptors: their interactions in antinociception, tolerance and neuroplasticity

被引:213
作者
Mao, JR [1 ]
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, MGH Pain Ctr, Boston, MA 02114 USA
关键词
NMDA; opioid receptor; interaction;
D O I
10.1016/S0165-0173(99)00020-X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Over the last several years, significant progress has been made in our understanding of interactions between the N-methyl-D-aspartate (NMDA) and opioid receptors. Such interactions have been demonstrated at. two distinct sites: (1) modulation of NMDA receptor-mediated electrophysiological events by opioids; and (2) intracellular events involving interactions between NMDA and opioid receptors. Furthermore, a considerable number of studies have shown the involvement of such interactions in neural mechanisms of nociceptive transmission, antinociception in acute and chronic pain states, opioid tolerance/dependence, and neuroplasticity. Importantly, emerging evidence indicates that activation of NMDA receptors may differentially modulate functions mediated by distinct opioid receptor subtypes, namely mu, delta, and kappa receptors. These studies have greatly enriched our knowledge regarding both NMDA and opioid receptor systems and have shed light on neurobiology of both acute and chronic pain. The advancement of such knowledge also promotes new strategies for better clinical management of pain patients. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:289 / 304
页数:16
相关论文
共 140 条
[11]   Blockade of the polyamine site of NMDA receptors produces antinociception and enhances the effect of morphine, in mice [J].
Bernardi, M ;
Bertolini, A ;
Szczawinska, K ;
Genedani, S .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 298 (01) :51-55
[12]   Intraaccumbens administration of NMDA receptor antagonist (+/-)-CPP prevents locomotor activation conditioned by morphine and amphetamine in rats [J].
Bespalov, AY ;
Zvartau, EE .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1996, 55 (02) :203-207
[13]   EFFECT OF DIZOCILPINE (MK-801) ON ANALGESIA AND TOLERANCE INDUCED BY U-50,488H, A KAPPA-OPIOID RECEPTOR AGONIST, IN THE MOUSE [J].
BHARGAVA, HN ;
THORAT, SN .
BRAIN RESEARCH, 1994, 649 (1-2) :111-116
[14]   Enhancement of morphine actions in morphine-naive and morphine-tolerant mice by LY 235959, a competitive antagonist of the NMDA receptor [J].
Bhargava, HN .
GENERAL PHARMACOLOGY, 1997, 28 (01) :61-64
[15]   Modification of the binding of [H-3]MK-801 to brain regions and spinal cord of rats treated chronically with U-50,488H, a kappa-opioid receptor agonist [J].
Bhargava, HN ;
Kumar, S .
BRAIN RESEARCH, 1997, 749 (02) :347-350
[16]   NONCOMPETITIVE ANTAGONISM OF N-METHYL-D-ASPARTATE RECEPTOR INHIBITS TOLERANCE TO THE ANALGESIC ACTION OF U-50,488H, A KAPPA-OPIATE RECEPTOR AGONIST IN THE RAT [J].
BHARGAVA, HN .
GENERAL PHARMACOLOGY, 1995, 26 (05) :1055-1060
[17]  
BHARGAVA HN, 1995, PHARMACOLOGY, V51, P323
[18]   Differential effects of LY235959, a competitive antagonist of the NMDA receptor on kappa-opioid receptor agonist induced responses in mice and rats [J].
Bhargava, HN ;
Thorat, SN .
BRAIN RESEARCH, 1997, 747 (02) :246-251
[19]   Effects of N-methyl-D-aspartate receptor antagonists on the analgesia and tolerance to D-Ala(2),Glu(4) deltorphin II, a delta(2)-opioid receptor agonist in mice [J].
Bhargava, HN ;
Zhao, GM .
BRAIN RESEARCH, 1996, 719 (1-2) :56-61
[20]  
Bilsky EJ, 1996, J PHARMACOL EXP THER, V277, P484